International price comparisons for national price-negotiated drugs in China: a cross-regional analysis
Health Policy and Planning · 18.08.2025 · 40 (7) · 753-764
DOI: 10.1093/heapol/czaf040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Policy and Planning, online erschienen am 28.06.2025. Verfasst von Lanting Lyu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Population and Health, Renmin University of China, No. 59 Zhongguancun Street, Haidian District, Beijing, 100872, China. Hauptthemen laut MEDLINE: Drug Costs, Commerce, Negotiating. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
China has long struggled with high medical costs and irrational drug pricing but has recently made significant progress by implementing drug negotiation strategies to effectively reduce the prices of targeted drugs. To accurately depict drug prices on a global scale, a cross-sectional time-series analysis was conducted in China using Multinational Integrated Data Analysis System data from the first quarter of 2017 to the fourth quarter of 2022. This analysis compared the prices of 140 price-negotiated innovative drugs across 15 countries using five distinct price indices—Average Price Index, Laspeyres, Paasche, Fisher, and Chained Laspeyres—aiming to address gaps in understanding China’s negotiated drug prices globally. The five drug price index (DPI) showed general consistency and revealed significant variations in drug prices across countries. China's drug pricing reforms have successfully reduced drug costs and alleviated the financial burden on patients, offering insights for other developing countries. Drug price indices serve as valuable tools for monitoring prices and promoting transparency, while using PPPs may better reflect actual affordability and provide a more reasonable assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Population and Health, Renmin University of China, No. 59 Zhongguancun Street, Haidian District, Beijing, 100872, China.
- Health Technology Assessment and Policy Evaluation Group, Renmin University of China, No. 59 Zhongguancun Street, Haidian District, Beijing, 100872, China.
- Real World Solutions, IQVIA China, 9F, Crystal Plaza T1, 1359 Yaolong Road, Pudong, Shanghai, 200124, China.
ORCID-Profile: Lanting Lyu
Zitieren
APA
Lyu, L., Hu, Q., Zou, Y., & Ming, J. (2025). International price comparisons for national price-negotiated drugs in China: a cross-regional analysis. Health Policy and Planning, 40(7), 753-764. https://doi.org/10.1093/heapol/czaf040
Vancouver
Lyu L, Hu Q, Zou Y, Ming J. International price comparisons for national price-negotiated drugs in China: a cross-regional analysis. Health Policy and Planning. 2025;40(7):753-764. doi:10.1093/heapol/czaf040
BibTeX
@article{Lyu2025,
author = {Lyu, Lanting and Hu, Qiuru and Zou, Yuanfang and Ming, Jian},
title = {International price comparisons for national price-negotiated drugs in China: a cross-regional analysis},
journal = {Health Policy and Planning},
year = {2025},
volume = {40},
number = {7},
pages = {753--764},
doi = {10.1093/heapol/czaf040}
}
EUVIMED